CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway is a research paper published in Neurotherapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: U54CA210190-5
National Institute of Neurological Disorders and Stroke
Grant: NS091555
National Institute of Neurological Disorders and Stroke
Grant: NS094804
National Institute of Neurological Disorders and Stroke
Grant: NS074387
NINDS NIH HHS
Grant: R01 NS074387
NINDS NIH HHS
Grant: R21 NS091555
NINDS NIH HHS
Grant: R37 NS094804
NCI NIH HHS
Grant: U54 CA210190
NIDA NIH HHS
Grant: T32 DA007097
National Institutes of Health
Grant: 1R21NS091555-01
HDL-Loaded Nanoparticles for Glioma Therapeutics
National Institutes of Health
Grant: 7R01NS074387-02
Crosstalk between glioma cells & immune cells in the tumor microenvironment: Ther
National Institutes of Health
Grant: 5R37NS094804-06
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic Strategies
National Institutes of Health
Grant: 3U54CA210190-03S3
Center for Modeling Tumor Cell Migration Mechanics
Randy Shaver Cancer Research and Community Fund
Children’s’ Cancer Research Foundation Cancer Research
Hyundai Hope On Wheels
Humor to Fight the Tumor
Musella Foundation For Brain Tumor Research and Information
Addenbrooke's Charitable Trust, Cambridge University Hospitals
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals